Skandinaviska Enskilda Banken Ab (Publ) Krystal Biotech, Inc. Transaction History
Skandinaviska Enskilda Banken Ab (Publ)
- $19.9 Billion
- Q1 2025
A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 59,978 shares of KRYS stock, worth $7.58 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
59,978
Previous 89,047
32.64%
Holding current value
$7.58 Million
Previous $14 Million
22.48%
% of portfolio
0.05%
Previous 0.06%
Shares
15 transactions
Others Institutions Holding KRYS
# of Institutions
328Shares Held
24.3MCall Options Held
299KPut Options Held
97.6K-
Black Rock Inc. New York, NY3.95MShares$499 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.83MShares$357 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.73MShares$345 Million7.97% of portfolio
-
State Street Corp Boston, MA1.23MShares$155 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA954KShares$121 Million0.03% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.25B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...